Cytosorbents Corporation

NasdaqCM:CTSO 株式レポート

時価総額:US$54.4m

Cytosorbents 過去の業績

過去 基準チェック /06

Cytosorbentsの収益は年間平均-15.7%の割合で減少していますが、 Medical Equipment業界の収益は年間 増加しています。収益は年間13.1% 5.3%割合で 増加しています。

主要情報

-15.7%

収益成長率

-7.6%

EPS成長率

Medical Equipment 業界の成長8.9%
収益成長率5.3%
株主資本利益率-152.5%
ネット・マージン-68.7%
次回の業績アップデート07 Nov 2024

最近の業績更新

Recent updates

The Market Lifts Cytosorbents Corporation (NASDAQ:CTSO) Shares 43% But It Can Do More

Oct 01
The Market Lifts Cytosorbents Corporation (NASDAQ:CTSO) Shares 43% But It Can Do More

Investors Continue Waiting On Sidelines For Cytosorbents Corporation (NASDAQ:CTSO)

Jul 04
Investors Continue Waiting On Sidelines For Cytosorbents Corporation (NASDAQ:CTSO)

Health Check: How Prudently Does Cytosorbents (NASDAQ:CTSO) Use Debt?

Mar 16
Health Check: How Prudently Does Cytosorbents (NASDAQ:CTSO) Use Debt?

Take Care Before Jumping Onto Cytosorbents Corporation (NASDAQ:CTSO) Even Though It's 28% Cheaper

Jan 06
Take Care Before Jumping Onto Cytosorbents Corporation (NASDAQ:CTSO) Even Though It's 28% Cheaper

Is Cytosorbents (NASDAQ:CTSO) Using Too Much Debt?

Nov 10
Is Cytosorbents (NASDAQ:CTSO) Using Too Much Debt?

Shareholders Should Be Pleased With Cytosorbents Corporation's (NASDAQ:CTSO) Price

Jul 13
Shareholders Should Be Pleased With Cytosorbents Corporation's (NASDAQ:CTSO) Price

Health Check: How Prudently Does Cytosorbents (NASDAQ:CTSO) Use Debt?

May 16
Health Check: How Prudently Does Cytosorbents (NASDAQ:CTSO) Use Debt?

We're A Little Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate

Mar 08
We're A Little Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate

CytoSorbents secures $4.3M contract by U.S. Department of Defense

Oct 06

CytoSorbents stock rises on US DoD contract to develop device for universal plasma

Sep 09

We're A Little Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate

Sep 02
We're A Little Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate

CytoSorbents gets reimbursement for CytoSorb in Turkey

Aug 23

CytoSorbents stock rises 10% as Israel approves coverage for CytoSorb system

Aug 17

Cytosorbents GAAP EPS of -$0.25 misses by $0.13, revenue of $8.5M misses by $1.06M

Aug 02

収支内訳

Cytosorbents の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NasdaqCM:CTSO 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
30 Jun 2437-263712
31 Mar 2437-283714
31 Dec 2336-293716
30 Sep 2337-233615
30 Jun 2336-263615
31 Mar 2335-313615
31 Dec 2235-333715
30 Sep 2236-413918
30 Jun 2238-363819
31 Mar 2241-294018
31 Dec 2143-253816
30 Sep 2144-163713
30 Jun 2145-103610
31 Mar 2143-9339
31 Dec 2041-8329
30 Sep 2036-112910
30 Jun 2032-172811
31 Mar 2028-182612
31 Dec 1925-192412
30 Sep 1924-212411
30 Jun 1923-172210
31 Mar 1923-19238
31 Dec 1823-17238
30 Sep 1821-15217
30 Jun 1819-14216
31 Mar 1817-10184
31 Dec 1715-9163
30 Sep 1714-11153
30 Jun 1712-10144
31 Mar 1711-11134
31 Dec 1610-12134
30 Sep 168-9104
30 Jun 167-10104
31 Mar 166-594
31 Dec 155-984
30 Sep 154-1784
30 Jun 154-1774
31 Mar 154-2173
31 Dec 144-1962
30 Sep 144-951
30 Jun 144-851
31 Mar 143-741
31 Dec 132-732

質の高い収益: CTSOは現在利益が出ていません。

利益率の向上: CTSOは現在利益が出ていません。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: CTSOは利益が出ておらず、過去 5 年間で損失は年間15.7%の割合で増加しています。

成長の加速: CTSOの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: CTSOは利益が出ていないため、過去 1 年間の収益成長をMedical Equipment業界 ( 12.2% ) と比較することは困難です。


株主資本利益率

高いROE: CTSOは現在利益が出ていないため、自己資本利益率 ( -152.54% ) はマイナスです。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘